The fear that human gene patents pose a threat to whole-genome sequencing is based largely on widely held misconceptions.
Subscribe to Journal
Get full journal access for 1 year
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Association for Molecular Pathology v. U.S. Patent and Trademark Office, 653 F.3d 1329 (Fed. Cir. 2011) http://www.patentdocs.org/2011/07/federal-circuit-issues-decision-in-amp-v-uspto.html (accessed 16 January 2012).
Utility Examination Guidelines, 66 Fed. Reg. 1092 (January 5, 2001).
Jensen, K. & Murray, F. Science 310, 239–240 (2005).
More specifically, they conducted an automated search to identify all US patents reciting the canonical term “SEQ ID NO.” in the claims, and wherein the “SEQ ID NO.” term is used in conjunction with a specific genetic sequence corresponding to a known human gene. Jensen & Murray's Supporting Online Material, available at http://www.sciencemag.org/cgi/data/310/5746/239/DC1/1 (last visited January 16, 2012).
Holman, C.M. Science 322, 198–199 (2008).
The query employed by Jensen & Murray identified as 'gene patents' patents that claimed proteins by reference to the DNA sequence encoding the protein, or by reference to a SEQ ID NO. that identified not only a DNA sequence, but also the amino acid sequence encoded by the DNA sequence.
Price, W.N. II Cardozo L. Rev. 33, (2012). http://ssrn.com/abstract=1914560
Holman, C.M. IP Theory 2, 4–7 (2011).
Anonymous. Single Molecule Real Time (SMRT™) DNA Sequencing (Pacific Biosciences, 2009) http://www.pacificbiosciences.com/assets/files/pacbio_technology_backgrounder.pdf (accessed 16 January 2012).
Personal communication, R. Cook-Deegan.
Brief of Amici Curiae Christopher M. Holman and Robert Cook-Deegan, Association for Molecular Pathology v. US PTO, Federal Circuit Docket Number 2010–1406, 2010 WL 4853323 (2010).
Billups-Rothenberg, Inc. v. Associated Regional and University Pathologists, Inc., 1401.pdf 642 F.3d 1031 (Fed. Cir 2011) http://www.patentlyo.com/files/10-1401.pdf (accessed 16 January 2012).
Oral argument in Association for Molecular Pathology v. US Patent and Trademark Office, Federal Circuit Docket Number 10–1406 http://www.cafc.uscourts.gov/oral-argument-recordings/search/audio.html at 55–56 minutes into the proceedings (accessed 16 January 2012).
Kepler, T.B., Crossman, C. & Cook-Deegan, R. Genomics 95, 312–314 (2010).
Davies, K. The $1,000 Genome: the Revolution in DNA Sequencing and the New Era of Personalized Medicine (Free Press, New York, 2010).
Holman, C. Myriad Genetics files amicus briefs in joint infringement cases Akamai and McKesson. Holman's Biotech IP Blog (24 July 2011) http://holmansbiotechipblog.blogspot.com/2011/07/myriad-genetics-files-amicus-briefs-in.html
Secretary's Advisory Committee on Genetics, Health, and Society. Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. (US Department of Health and Human Services, April 2010) http://oba.od.nih.gov/oba/sacghs/reports/SACGHS_patents_report_2010.pdf (accessed 16 January 2012).
Huys, I. et al. Nat. Biotechnol. 27, 903–909 (2009).
Cook-Deegan, R. & Heaney, C. Annu. Rev. Genomics Hum. Genet. 11, 383–414 (2010).
Amgen v. Chugai, 927 F.2d 1200 (Fed. Cir. 1991).
http://portal.uspto.gov/external/portal/pair (accessed 16 January 2012).
Moran, N. Nat. Biotechnol. 30, 3–5 (2012).
Holman, C.M. Gene patents under fire: weighing the costs and benefits. in Biotechnology and Software Patent Law: a Comparative Review of New Developments. (Arezzo, E. & Ghidini, G., eds.) (Edward Elgar Publishing, 2011). Draft manuscript, http://ssrn.com/abstract=1710150 (accessed 16 January 2012).
This research was conducted with financial support from the Biotechnology Industry Organization (BIO). The design, analysis and composition of this manuscript was conducted independently by me, and I am responsible for any errors or omissions. The views and conclusions expressed herein are my own, and do not necessarily reflect the views of BIO or any of its members. I am grateful to K. Jensen and F. Murray for sharing their patent data, and R. Cook-Deegan for helpful commentary.
The author declares no competing financial interests.
About this article
Cite this article
Holman, C. Debunking the myth that whole-genome sequencing infringes thousands of gene patents. Nat Biotechnol 30, 240–244 (2012). https://doi.org/10.1038/nbt.2146
American Economic Review (2019)
Legume information system (LegumeInfo.org): a key component of a set of federated data resources for the legume family
Nucleic Acids Research (2016)
Expanded Genetic Codes in Next Generation Sequencing Enable Decontamination and Mitochondrial Enrichment
PLoS ONE (2014)
SSRN Electronic Journal (2014)
European Journal of Human Genetics (2014)